US pharmaceutical giant Pfizer announced Monday it reached a deal to buy biotech firm Seagen, specialising in innovative cancer treatment, for $43 billion.

"Pfizer is deploying its financial resources to advance the fight against cancer," said Pfizer CEO Albert Bourla.